The protein kinase B/mechanistic target of rapamycin pathway, a critical pathway in tumor cell growth and metabolic regulation, upon aberrant activation, can enhance cell cycle progression and accelerate HCC progression (Bang et al., 2023). This evidence concerns the gene MTOR and hepatocellular carcinoma.